Physician

Manoj K Patel, M.D.

According to 2025 Medicare claims, Manoj Patel, M.D. (NPI: 1104817808) practices nephrology in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF COLUMBUS, P.C. (NPI: 1689767295; TIN: 581838897) and primary practice location at 31904-6863.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 750 traditional Medicare patients, billed 4,276 HCPCS/CPT codes, and received $426,991 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,978 prescription claims across 434 beneficiaries totaling $91,648 in drug costs, led by Sps (Sodium Polystyrene Sulfon/Sorb). DME data shows 124 claims. Open Payments data shows 7 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $445,575 to $91,648. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	874	6,469	$453,337
2016	892	6,410	$463,721
2017	856	5,738	$420,604
2018	904	5,625	$427,506
2019	945	5,820	$407,394
2020	756	4,121	$306,889
2021	746	4,336	$382,419
2022	844	4,632	$441,013
2023	889	5,155	$484,761
2024	750	4,276	$426,991

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	338	2,684	$445,575
2016	337	2,744	$512,653
2017	316	2,370	$482,517
2018	337	1,936	$231,091
2019	341	1,889	$135,871
2020	332	1,708	$93,098
2021	328	1,575	$86,566
2022	391	1,711	$109,040
2023	424	2,030	$148,801
2024	434	1,978	$91,648

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	41	$4,282
2017	N/R	54	$4,503
2018	N/R	113	$7,859
2019	N/R	126	$6,054
2020	N/R	171	$6,338
2021	N/R	154	$3,894
2022	N/R	104	$2,309
2023	N/R	148	$3,934
2024	N/R	124	$3,846

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	158	211	$139
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	258	737	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	397	996	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	172	453	$63
81002	Urinalysis, manual test	379	979	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sps	Sodium Polystyrene Sulfon/Sorb	25	751	$15,951
Eliquis	Apixaban	13	540	$9,681
Sevelamer Carbonate	Sevelamer Carbonate	34	1,485	$8,743
Calcium Acetate	Calcium Acetate	107	5,834	$8,455
Clonidine	Clonidine	12	672	$4,115

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	13	$1,621
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	24	$658
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	35	$614
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	33	$477
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	19	$476

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$30	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manoj K. Patel, M.D.?

Tedicare shows public-source Medicare data for Manoj K. Patel, M.D. (NPI 1104817808), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manoj K. Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Manoj K. Patel, M.D.?

Manoj K. Patel, M.D. is linked to NEPHROLOGY ASSOCIATES OF COLUMBUS, P.C. (billing NPI 1689767295) in the available physician profile data.

Does Manoj K. Patel, M.D. have Open Payments data?

Manoj K. Patel, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.